Martin Shkreli, former pharmaceutical executive
Martin Shkreli, the maligned former CEO of Turing Pharmaceuticals, was called before a Congressional committee this week to discuss his decision to increase the price of the drug Daraprim. Daraprim treats toxoplasmosis Read More…
